This powerful combination, we believe, will help unlock significant weight loss for our patients and hopefully many of the quality of life benefits that come along with it." The introduction of the Ro Body Program builds upon the success of Ro's existing weight loss offering
Based on the weight-loss correlation data, one would expect hair loss rates to be at least comparable to or potentially higher than those seen with semaglutide and tirzepatide
If you realize you missed your dose the next day, taking it as soon as you remember keeps your schedule on track
3436 The expected prevalence of NAFLD and NASH is expected to increase in the U.S
The SYNCHRONISE-CVOT trial will evaluate the cardiovascular safety of survodutide in participants with overweight or obesity and established CVD, chronic kidney disease or cardiovascular risk factors (clinical trial number NCT06077864
This fibrotic response, driven in part by the Smad3 pathway within the transforming growth factor beta family, is marked by collagen deposition and tissue scarring [14, 29]